Delivery Order SPE2DR25D2101-SPE2DR26F45NS
- Not listed
- The Defense Logistics Agency (DLA) awarded a $12,636.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on August 29, 2025, with a completion date of September 2, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,161.71 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on March 11, 2025, with completion scheduled for March 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $36,746.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,318.54 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors (0.5 mL). This competitive, firm fixed-price delivery order was executed on July 14, 2025, with a completion date of July 15, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,062.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on September 22, 2025, with an ultimate completion date of September 23, 2025. This award was made under firm fixed-price terms with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injections. This competitively awarded, non-set-aside contract has a ceiling value of $10,683.61 with a firm fixed price structure and is scheduled for completion by May 5, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,016.78 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed price contract, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.86 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on September 24, 2025. This contract utilizes firm fixed pricing and was competitively awarded without any set-aside designation. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance at the company's headquarters in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by September 25,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,785.41 on June 17, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This non-competitive, firm fixed-price delivery order is expected to be completed by June 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,665.17 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injectors with an ultimate completion date of August 4, 2025. This competitive award (no set-aside designation) utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the prime contractor's location in...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F45NSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,798.97 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of November 10, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a discrete purchase under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. This delivery order falls under AmerisourceBergen Drug Corp's $999.999 billion prime IDC (designated SPE2DX) with the DLA, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As one of the nation's leading pharmaceutical distributors, AmerisourceBergen supplies an extensive portfolio of medications and medical supplies to support Defense Health Agency operations and other federal healthcare systems. The Zepbound delivery represents a routine pharmaceutical procurement consistent with the company's established role as a critical vendor for federal medical supply chains, particularly for medications supporting military personnel healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 11/7/25 |